188 related articles for article (PubMed ID: 29989015)
1. MiR-98 modulates macrophage polarization and suppresses the effects of tumor-associated macrophages on promoting invasion and epithelial-mesenchymal transition of hepatocellular carcinoma.
Li L; Sun P; Zhang C; Li Z; Cui K; Zhou W
Cancer Cell Int; 2018; 18():95. PubMed ID: 29989015
[TBL] [Abstract][Full Text] [Related]
2. MiR-98 suppresses the effects of tumor-associated macrophages on promoting migration and invasion of hepatocellular carcinoma cells by regulating IL-10.
Li L; Sun P; Zhang C; Li Z; Zhou W
Biochimie; 2018 Jul; 150():23-30. PubMed ID: 29702181
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-37 suppresses hepatocellular carcinoma growth through inhibiting M2 polarization of tumor-associated macrophages.
Zhang Z; Zhang J; He P; Han J; Sun C
Mol Immunol; 2020 Apr; 122():13-20. PubMed ID: 32278133
[TBL] [Abstract][Full Text] [Related]
4. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
[TBL] [Abstract][Full Text] [Related]
5. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
Jiang Y; Han Q; Zhao H; Zhang J
J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
[TBL] [Abstract][Full Text] [Related]
6. S100A9 promotes tumor-associated macrophage for M2 macrophage polarization to drive human liver cancer progression: An in vitro study.
Yang LF; Zhang ZB; Wang L
Kaohsiung J Med Sci; 2023 Apr; 39(4):345-353. PubMed ID: 36807724
[TBL] [Abstract][Full Text] [Related]
7. Cantharidin exerts anti-hepatocellular carcinoma by miR-214 modulating macrophage polarization.
Lu S; Gao Y; Huang X; Wang X
Int J Biol Sci; 2014; 10(4):415-25. PubMed ID: 24719559
[TBL] [Abstract][Full Text] [Related]
8. miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization.
Lin X; Wang S; Sun M; Zhang C; Wei C; Yang C; Dou R; Liu Q; Xiong B
J Hematol Oncol; 2019 Feb; 12(1):20. PubMed ID: 30808369
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma.
Wei Q; Liu G; Huang Z; Huang Y; Huang L; Huang Z; Wu X; Wei H; Pu J
J Hepatocell Carcinoma; 2023; 10():1019-1035. PubMed ID: 37435155
[TBL] [Abstract][Full Text] [Related]
10. MiR-155 regulates M2 polarization of hepatitis B virus-infected tumour-associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma.
Fei Y; Wang Z; Huang M; Wu X; Hu F; Zhu J; Yu Y; Shen H; Wu Y; Xie G; Zhou Z
J Viral Hepat; 2023 May; 30(5):417-426. PubMed ID: 36704832
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma.
Hu Z; You L; Hu S; Yu L; Gao Y; Li L; Zhang S
Int Immunopharmacol; 2024 Jan; 126():111149. PubMed ID: 38006750
[TBL] [Abstract][Full Text] [Related]
12. 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages.
Wu Z; Zhou J; Chen F; Yu J; Li H; Li Q; Li W
Int Immunopharmacol; 2022 Mar; 104():108468. PubMed ID: 35066343
[TBL] [Abstract][Full Text] [Related]
13.
Li C; Pan XY; Ma M; Zhao J; Zhao F; Lv YP
Pharm Biol; 2021 Dec; 59(1):1533-1539. PubMed ID: 34726570
[TBL] [Abstract][Full Text] [Related]
14. M2-like tumor-associated macrophages promote epithelial-mesenchymal transition through the transforming growth factor β/Smad/zinc finger e-box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma.
Sumitomo R; Menju T; Shimazu Y; Toyazaki T; Chiba N; Miyamoto H; Hirayama Y; Nishikawa S; Tanaka S; Yutaka Y; Yamada Y; Nakajima D; Ohsumi A; Hamaji M; Sato A; Yoshizawa A; Huang CL; Haga H; Date H
Cancer Sci; 2023 Dec; 114(12):4521-4534. PubMed ID: 37806311
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
16. TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells.
Chen Y; Wen H; Zhou C; Su Q; Lin Y; Xie Y; Huang Y; Qiu Q; Lin J; Huang X; Tan W; Min C; Wang C
Exp Cell Res; 2019 May; 378(1):41-50. PubMed ID: 30844387
[TBL] [Abstract][Full Text] [Related]
17. NF-κB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a/NF-κB/Snail signaling in bladder cancer cells.
Zhang Q; Mao Z; Sun J
Gene; 2019 Aug; 710():91-97. PubMed ID: 31002892
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages promote human hepatoma Huh-7 cell migration and invasion through the Gli2/IGF-II/ERK1/2 axis by secreting TGF-β1.
Liu M; Zhong YB; Shao J; Zhang C; Shi C
Cancer Biol Ther; 2020 Nov; 21(11):1041-1050. PubMed ID: 33081566
[TBL] [Abstract][Full Text] [Related]
20. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
